Allorion Therapeutics
PrivateLast Round
Series B
Mar 9, 2023
Total Funding Raised
$105M
Company Overview
Allorion Therapeutics is a biopharmaceutical company that develops innovative small-molecule drugs aimed at treating cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allorion Therapeutics Comparables
Compare Allorion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avenzo Therapeutics | 84% | |
| NiKang Therapeutics | 84% | |
| AnHorn Medicines | 83% | |
Allorion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 9, 2023 | ||||
| Series A | Nov 24, 2021 | ||||
| Angel | Jul 1, 2020 |
Key People
Founding team and executive leadership
Allorion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longriver Investment Partners | Series B |
| IDG Capital | Series A |
| Firstred Capital | Series A |
| TF Capital | Angel, Series A, Series B |
| 渶策资本 | Series B |
| Elikonventure.com | Series A, Series B |
| LongRiver Investments | Series B |
Allorion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allorion Therapeutics's valuation, stock price, and market status.